Qube Research & Technologies (QRT)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Buy
230
+80
+53% +$4.69K ﹤0.01% 3249
2026
Q1
$8.11K Buy
150
+144
+2,400% +$8.03K ﹤0.01% 3349
2025
Q4
$336 Buy
6
+4
+200% +$207 ﹤0.01% 3621
2025
Q3
$96 Hold
2
﹤0.01% 3518
2025
Q2
$81 Hold
2
﹤0.01% 3499
2025
Q1
$88 Sell
2
-21
-91% -$927 ﹤0.01% 3437
2024
Q4
$989 Sell
23
-511
-96% -$23.2K ﹤0.01% 3387
2024
Q3
$23.7K Buy
534
+391
+273% +$16.7K ﹤0.01% 2956
2024
Q2
$5.69K Sell
143
-4
-3% -$162 ﹤0.01% 3023
2024
Q1
$6.34K Sell
147
-36
-20% -$1.55K ﹤0.01% 3859
2023
Q4
$7.62K Hold
183
﹤0.01% 3651
2023
Q3
$7.27K Buy
183
+4
+2% +$169 ﹤0.01% 3386
2023
Q2
$7.34K Sell
179
-40
-18% -$1.65K ﹤0.01% 2231
2023
Q1
$8.98K Sell
219
-625
-74% -$26.3K ﹤0.01% 2373
2022
Q4
$34.6K Buy
+844
New +$35.1K ﹤0.01% 2183
2022
Q2
Sell
-12
Closed -$1K 3211
2022
Q1
$1K Sell
12
-144
-92% -$6.33K ﹤0.01% 2379
2021
Q4
$7K Sell
156
-244
-61% -$11.6K ﹤0.01% 2430
2021
Q3
$19K Sell
400
-175
-30% -$8.7K ﹤0.01% 1981
2021
Q2
$30K Buy
+575
New +$28.9K ﹤0.01% 2064

Other funds holding XPH

Qube Research & Technologies (QRT)'s XPH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 53% in Q2 2026, buying an estimated $4.69K and bringing the position to 230 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3249.

Qube Research & Technologies (QRT) first reported a position in XPH in Q2 2021 and has held it in 19 quarters since. The position peaked at $34.6K in Q4 2022. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 230 shares of State Street SPDR S&P Pharmaceuticals ETF worth $15.2K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 80 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $4.69K.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3249 holding.
  • Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2021 and has held it in 19 quarters since.
  • Qube Research & Technologies (QRT)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $34.6K in Q4 2022.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.